Sky Centy Invt Stock Price, News & Analysis
Company Description
Sky Centy Invt (OTC Link: SKYI) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $469.4K.
SKYI stock has gained 370.3% over the past year. Shares last traded at $0.0043.
On a trailing twelve-month basis, Sky Centy Invt reported revenue of $76K with net income of -$117K. The company operates at a net profit margin of -153.6%.
This page provides a comprehensive overview of SKYI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sky Centy Invt (SKYI) stock last traded at $0.0043. Over the past 12 months, the stock has gained 370.3%. At a market capitalization of $469.4K, SKYI is classified as a micro-cap stock with approximately 2.2M shares outstanding.
SKYI Rankings
Latest News
Sky Centy Invt has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all SKYI news →
SEC Filings
Sky Centy Invt has filed 4 recent SEC filings, including 2 Form 10-Q, 1 Form 8-K, 1 Form 10-K. The most recent filing was submitted on April 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SKYI SEC filings →
Financial Highlights
Sky Centy Invt generated $76K in revenue over the trailing twelve months, retaining a 32.1% gross margin, operating income reached -$117K (-152.8% operating margin), and net income was -$117K, reflecting a -153.6% net profit margin. The company generated $46K in operating cash flow. With a current ratio of 0.01, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Sky Centy Invt (SKYI) currently stands at 30 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Sky Centy Invt (SKYI) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
SKYI Company Profile & Sector Positioning
Sky Centy Invt (SKYI) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SKYI often look at related companies in the same sector, including Noveris Health Sciences Inc (MYCOF), North Amern Cannabis Hldgs Inc (USMJ), Branded Legacy Inc (BLEG), Real Brands (RLBD), and Pazoo Inc (PZOO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SKYI's relative position within its industry.